FDAnews Announces -- Develop World-Class SOPs that Minimize Human Error Improve Your Productivity, Quality and Regulatory Standing Webinar, Oct. 31, 2019
FALLS CHURCH, Va., Oct. 17, 2019 /PRNewswire-PRWeb/ -- Develop World-Class SOPs that Minimize Human Error Improve Your Productivity, Quality and Regulatory Standing **An FDAnews Webinar** Thursday, Oct. 31, 2019, 1:00-2:30 p.m. EDT https://www.fdanews.com/developsops
Looking to improve the organization's productivity, quality and regulatory success? SOPs are key.
Most regulatory citations are related to procedures. And procedures account for more than 40% of human error events in manufacturing. By improving SOPs, one will minimize both human error and regulatory citations.
How does one go about it?
Human Error Solutions' CEO, Ginette Collazo, Ph.D. ? an industrial-organizational psychologist and one of the world's few human error reduction experts ? will explain:
How to prepare an outline and develop world-class SOPs
The interrelationship between SOPs, quality and regulatory compliance
Why human error is a root cause for lack of quality and how to minimize it
Common mistakes and causes of human error
How to create and maintain a procedure that minimizes human error
Good procedure writing practices: terminology, formats, layouts, mixed cases, steps content, familiar words, references, branching, conditional steps and the use of precautions, warnings and cautions
Use of electronic information networks for procedural access
While human error may never be eliminated completely, one will come away with clear guidance to help have SOPs that minimize such issues to avoid human error events and regulatory citations.
Interested in registering multiple sites? Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally to learn about our special multisite discount.
Webinar Details: Develop World-Class SOPs that Minimize Human Error Improve Your Productivity, Quality and Regulatory Standing **An FDAnews Webinar** Thursday, Oct. 31, 2019, 1:00-2:30 p.m. EDT https://www.fdanews.com/developsops
About FDAnews: FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations
Digicann Ventures Ltd. ("Digicann" or the "Company") , a company focused on opportunities within and outside of the cannabis industry, announces that it has entered into an agreement with holders of the Company's 10.00% Senior Unsecured Convertible...
DelveInsight's Alport Syndrome Market Insights report includes a comprehensive understanding of current treatment practices, Alport syndrome emerging drugs, market share of individual therapies, and current and forecasted market size from 2020 to...
NanoString Technologies, Inc. ("NanoString" or "the Company"), a leading provider of life science tools for discovery and translational research, today announced that substantially all of its assets will be acquired by Bruker Corporation ("Bruker"),...
Benchmark Senior Living, the largest senior housing provider in New England, today announced that 44 of its Northeast continuing care, independent living, assisted living and Mind & Memory Care communities have been named U.S. News & World Report...
Pieper Veterinary, a Northeastern-based family of primary, specialty, and emergency care veterinary hospitals, is excited to announce they have partnered with Lebanon Veterinary Hospital in Lebanon CT. This partnership continues Pieper's strategy to...
NRx Pharmaceuticals, Inc. ("NRx Pharmaceuticals" or the "Company"), a clinical-stage biopharmaceutical company, today announced that it intends to offer to sell shares of its common stock in an underwritten public offering. All of the shares of...